Arbutus Biopharma (ABUS) Receivables - Other (2010 - 2018)
Arbutus Biopharma (ABUS) posted Receivables - Other of $128000.0 for Q1 2018, little changed sequentially from $128000.0 in Q4 2017, and little changed YoY from $128000.0 in Q1 2017.
Arbutus Biopharma (ABUS) Receivables - Other (2010 - 2018) Analysis & Trends
Arbutus Biopharma has reported Receivables - Other for 9 years, with the latest figure at $128000.0 in Q1 2018.
- Quarterly Receivables - Other changed 0.0% year-over-year to $128000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $128000.0 (changed 0.0% YoY) and the FY2017 annual result came in at $128000.0, changed 0.0% from the prior year.
- Receivables - Other steadied at $128000.0 in Q1 2018 per ABUS's latest filing, from $128000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $1.6 million in Q1 2015 and troughed at $128000.0 in Q4 2015.
- A 5-year average of $291411.8 and a median of $128000.0 in 2015 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2014 and 2016: Receivables - Other soared 249602.92% in 2014, then slumped 91.97% in 2016.
- Over 5 years, Receivables - Other stood at $538000.0 in 2014, then tumbled by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
- According to Business Quant data, Receivables - Other over the past three periods registered $128000.0, $128000.0, and $128000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 128,000.00 |
| Mar 31, 2018 | 128,000.00 |
| Dec 31, 2017 | 128,000.00 |
| Dec 31, 2017 | 128,000.00 |
| Sep 30, 2017 | 128,000.00 |
| Sep 30, 2017 | 128,000.00 |
| Jun 30, 2017 | 128,000.00 |
| Jun 30, 2017 | 128,000.00 |
| Mar 31, 2017 | 128,000.00 |
| Mar 31, 2017 | 128,000.00 |
| Dec 31, 2016 | 128,000.00 |
| Dec 31, 2016 | 128,000.00 |
| Sep 30, 2016 | 128,000.00 |
| Sep 30, 2016 | 128,000.00 |
| Jun 30, 2016 | 128,000.00 |
| Jun 30, 2016 | 128,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Dec 31, 2015 | 128,000.00 |
| Dec 31, 2015 | 128,000.00 |